2024 annual financial data
MoonLake Immunotherapeutics 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -143,091,082 USD and net income was -118,935,517 USD.
Operating cash flow was -116,587,263 USD.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -143,091,082 USD
- Net income
- -118,935,517 USD
- Operating cash flow
- -116,587,263 USD